Objectives: Computer-aided detection (CAD) for CT colonography (CTC) has been developed to detect benign polyps in asymptomatic patients. We aimed to determine whether such a CAD system can also detect cancer in symptomatic patients. Methods: CTC data from 137 symptomatic patients subsequently proven to have colorectal cancer were analysed by a CAD system at 4 different sphericity settings: 0, 50, 75 and 100. CAD prompts were classified by an observer as either true-positive if overlapping a cancer or false-positive if elsewhere. Colonoscopic data were used to aid matching. Results: Of 137 cancers, CAD identified 124 (90.5%), 122 (89.1%), 119 (86.9%) and 102 (74.5%) at a sphericity of 0, 50, 75 and 100, respectively. A substantial proportion of cancers were detected on either the prone or supine acquisition alone. Of 125 patients with prone and supine acquisitions, 39.3%, 38.3%, 43.2% and 50.5% of cancers were detected on a single acquisition at a sphericity of 0, 50, 75 and 100, respectively. CAD detected three cancers missed by radiologists at the original clinical interpretation. Falsepositive prompts decreased with increasing sphericity value (median 65, 57, 45, 24 per patient at values of 0, 50, 75, 100, respectively) but many patients were poorly prepared. Conclusion: CAD can detect symptomatic colorectal cancer but must be applied to both prone and supine acquisitions for best performance. CT colonography (CTC) is increasingly used as a relatively non-invasive method of colonic investigation both for colorectal cancer screening [1,2] and in patients with symptoms suggestive of colorectal cancer [3][4][5][6]. Despite the advent of modern visualisation workstations, accurate interpretation of CTC is known to be difficult and requires substantial observer training [7][8][9][10]. It has been suggested that computer-aided detection (CAD) may enhance reader performance and perhaps also diminish the learning curve for CTC [11,12]. Recent studies confirm that reader sensitivity is increased when interpretation is supplemented by CAD [13][14][15][16].Most claims for the potential benefits of CAD have been made in the context of colorectal cancer screening [12,17], which targets both early cancer and its precursor, the adenomatous polyp. In asymptomatic individuals, the prevalence of adenomas vastly exceeds that of early cancer and so CAD systems have naturally been optimised for polyp detection. However, CTC is also advocated for symptomatic patients, in whom the prevalence of established carcinoma is much higher [18]. Even then, symptoms suggesting cancer are both nonspecific and common in the general population, with the result that most patients investigated do not actually have cancer [18], and CAD to assist diagnosis of colorectal cancer is therefore an attractive concept. Cancers, like polyps, are usually characterised by softtissue protrusion into the bowel lumen. It is therefore possible that CAD systems may serendipitously identify cancers. We aimed to determine whether a CAD system developed to detect co...